BMI of 30 or above, or BMI of 27 or above with an obesity-related health condition Health conditions such as high blood pressure, insulin resistance, sleep apnea, or elevated cholesterol History of unsuccessful attempts with diet, exercise, or commercial weight loss programs Willingness to combine medication with nutrition, movement, and lifestyle changes Not currently pregnant or planning pregnancy in the near term No contraindications to GLP-1 therapy based on health history and provider review Candidacy for compounded semaglutide and compounded tirzepatide is reviewed individually
Oral optionsespecially liposomal formsare great for ongoing, daily support and maintenance
At maintenance doses, though, Mounjaro has become significantly more expensive after the 170% price increase in September 2025
The results are pretty impressive
Oba preparaty s dostpne w formie wstrzykni podskrnych, a wymagana czsto zastrzykw to 1 raz na dob o staej porze dnia
The time it takes the body to process medication is not the same for everyone